Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
- Nanotechnology for drug design, delivery and applications
2. Biogenic nanoparticles: synthesis, mechanism, characterization and applications
3. Phytonanotechnology: A greener approach for biomedical applications
4. Microbial enzymes mediated biosynthesis of metal nanoparticles
5. Green nanotechnology: Isolation of bioactive molecules and modified approach of bio-synthesis
6. Green synthesis of Inorganic Nanoparticles and their cancer theranostics applications
7. Biosynthesized silver nanoparticles as cancer theranostic agents
8. Biosynthesized gold nanoparticles as cancer theranostic agents
9. Mechanisms underlying the anticancer applications of biosynthesized nanoparticles
10. Hurdles for green nanomaterials as future cancer nanomedicine
Biogenic Nanoparticles for Cancer Theranostics outlines the synthesis of biogenic nanoparticles to become cancer theranostic agents. The book also discusses their cellular interaction and uptake, pharmacokinetics, biodistribution, drug delivery efficiency, and other biological effects. Additionally, the book explores the mechanism of their penetration in cancerous tissue, its clearance, and its metabolism. Moreover, the in vitro and in vivo toxicological effects of biogenic nanoparticles are discussed. This book is an important reference source for materials scientists and biomedical scientists who are looking to increase their understanding of how biogenic nanoparticles are being used for a range of cancer treatment types.
Metal nanoparticles have traditionally been synthesized by classical physico-chemical methods which have many drawbacks, such as high energy demand, high cost and potential ecotoxicity. As a result, the biosynthesis of metal nanoparticles is gaining increasing prominence. Biosynthesis approaches to metal nanoparticles are clean, safe, energy efficient and environment friendly.
- Explains the synthesis methods and applications of biogenic nanoparticles for cancer theranostics
- Outlines the distinctive features of biogenic nanoparticles that make them effective cancer treatment agents
- Assesses the major challenges of using biogenic nanoparticles on a mass scale
Materials scientists, biomedical scientists, cancer researchers
- No. of pages:
- © Elsevier 2021
- 1st June 2021
- Paperback ISBN:
Chittaranjan Patrareceived his B.Sc (1995) and M.Sc (1997) in Chemistry from the University of Burdwan, W.B. He was awarded the “Dr. Mrigendranath Ghosh Gold Medal” for obtaining first class and first rank in B.Sc Chemistry (Hons) Examination in 1995 from The University of Burdwan, India.He completed his Ph.D. in Chemistry in 2003 as CSIR Fellow(April 1998- March 2003) fromNational Chemical Laboratory (NCL), Pune.Thereafter, he received his postdoctoral experience (March 2003-October 2004) as ‘Nanotechnologist’ from Bar-Ilan University, Ramat-Gan, Israel. After that he moved to Mayo Clinic, Department of Biochemistry and Molecular Biology in October 2004 as postdoc followed by Assistant Professor in the same Department.Here Dr. Patra explored the field of nanobiotechnology for cancer and angiogenesis. Dr. Patra moved to CSIR-IICT-Hyderabad in 2010 after receiving prestigious Ramanujan Fellowship, from DST-New Delhi. Currently, Dr. Patra is working as Principal Scientistat Department of Applied Biology, CSIR-Indian Institute of Chemical Technology (IICT) and his research group is pursuing various nanomedicine research projects aimed at developing advanced nanomaterials and nanoparticles-based drug delivery systems (DDS) for treatment of cancer, cardiovascular and ischemic disease.
Principal Scientist, Department of Applied Biology, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, India
Irshad Ahmad is Associate Professor of Life Sciences Department at King Fahd University of Petroleum & Minerals, Saudi Arabia. His research focuses in the area of green nanobiotechnology and cellular metabolics.
Associate Professor, Life Sciences Department, King Fahd University of Petroleum and Minerals, Saudi Arabia
Muhammad Ayaz is a Lecturer at the Department of Pharmacy, University of Malakand, Pakistan. His research focuses on nanomaterials for drug delivery.
Lecturer, Department of Pharmacy, University of Malakand, Pakistan
Ali Talha Khalil is an Assistant Professor (Molecular Biology), in the Department of Pathology, Lady Reading Hospital – Medical Teaching Institution, located in Peshawar, Pakistan. His research focuses on nanobiotechnological approaches to answer pressing challenges in health, environment and industry.
Assistant Professor (Molecular Biology) Department of Pathology, Lady Reading Hospital – Medical Teaching Institution Peshawar, Pakistan
Sudip Mukherjee is a Research Fellow in Bioengineering at Rice University, USA. His research focuses on developing novel platforms of next generation therapeutics and diagnostics to improve the treatment of human diseases.
Research Fellow, Bioengineering, Rice University, USA
Muhammad Ovais is a Research Scientist at the CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), China. His research focuses on nanomedicine and cancer theranostics.
Research Scientist, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), China
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.